Read + Share
Amedeo Smart
Independent Medical Education
Leung J, Gray EB, Anderson TC, Sharkey SM, et al. Recombinant zoster vaccine (RZV) second-dose series completion in adults aged 50-64 years in the United States. Vaccine 2022 Nov 5. pii: S0264-410X(22)01328.PMID: 36347721
Email
LinkedIn
Facebook
Twitter
Privacy Policy